The Clinical Respiratory Journal 2024

3 papers
The 2024 edition of The Clinical Respiratory Journal features research primarily focused on thoracic oncology and surgical outcomes. Key studies address the management and prognosis of lung cancer, specifically examining predictive models for recurrence in early-stage non-small cell lung cancer (NSCLC) and the complications associated with pulmonary resections. Clinical investigations also explore multimodal treatment strategies, such as combining bronchoscopic interventions with immunotherapy for rare pulmonary malignancies like large cell neuroendocrine carcinoma. Significant contributions to the journal this year involve authors such as Jin Zhang, Bo Peng, and Lin Wang. The research emphasizes practical clinical tools, including the development of a nomogram for patient monitoring and reports on single-center experiences regarding unplanned perioperative reoperations. These works contribute to the understanding of surgical risks and the efficacy of emerging therapeutic combinations in respiratory medicine. This year's publications highlight a trend toward refining prognostic accuracy and evaluating the safety of surgical interventions in pulmonary care.

Top Research Directions

The 11 research directions with The Clinical Respiratory Journal 2024 papers, ranked by paper count, next to 2023. Share is the fraction of the edition’s papers in the direction.

#Direction20242023Share 2024Share 20232023 rank
1Evaluating Clinical Outcomes Using Historical Patient Cohorts1033.3%0.0%—
2Generalizability Limitations of Single Case Reports1033.3%0.0%—
3Integrating Heterogeneous Transcriptomic Data Across Experimental Platforms1033.3%0.0%—
4Machine Learning for Granular Prognostic Risk Stratification1033.3%0.0%—
5Multimodal Integration for Clinical Risk Stratification1033.3%0.0%—
6Predicting Post-Surgical Cancer Recurrence1033.3%0.0%—
7Predictive Modeling with Public Cancer Genomics Data1033.3%0.0%—
8Reversing T Cell Anergy with Immune Checkpoint Blockade1033.3%0.0%—
9Systemic Biases and Causal Limitations in Retrospective Studies1033.3%0.0%—
10The Hidden Pitfalls of Single Institution Datasets1033.3%0.0%—
11Tumor Mutational Burden as a Metric for Immunogenicity1033.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by The Clinical Respiratory Journal 2024 papers: a paper credits every institution named in its affiliations, once. 8 institutions share 3 credited papers.

#InstitutionPapersShare20232023 rank
1025ffea33 133.3%0—
202ez0zm48 133.3%0—
303108sf43 133.3%0—
4035wt7p80 133.3%0—
5037cjxp13 133.3%0—
6048q23a93 133.3%0—
7Nanjing Medical University 133.3%0—
8Xuzhou Medical College 133.3%0—

Download all institutions as CSV

About this data

Papers. The Clinical Respiratory Journal 2024 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2023 use shares, since the edition went from 1 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 3 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Clinical Respiratory Journal 2024”, https://lacuna.tiptreesystems.com/venue/the-clinical-respiratory-journal/2024.

Top Authors

AuthorPapers
Yanrong Ji1

Papers

Title
A Nomogram for Predicting Recurrence in Stage I Non‐Small Cell Lung Cancer
Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report
Unplanned Perioperative Reoperation Following Pulmonary Resection in Lung Cancer Patients: A Report of a Single‐Center Experience